{"transactions":[{"id":743391,"issuer":{"id":4394,"kind":"organization","name":"Rapport Therapeutics, Inc.","symbol":"RAPP"},"owners":[{"id":39726,"kind":"person","name":"Huber Reid M","position":1,"cik":"0001607052","reported_name":"Huber Reid M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-10T21:25:37.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":15200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option shall vest upon the earlier of (i) June 10, 2027 and (ii) the date of the next Annual Meeting of Stockholders of the Issuer, subject to the Reporting Person's continued service on such vesting date."}],"balance_after":15200,"derivative":{"exercise_price":35.21,"expiration_date":"2036-06-10","underlying":"Common Stock","underlying_shares":15200},"source":{"system":"sec-edgar","filing":"0001193125-26-266090","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2012593/000119312526266090/ownership.xml","form_type":"4"}},{"id":1040690,"issuer":{"id":4394,"kind":"organization","name":"Rapport Therapeutics, Inc.","symbol":"RAPP"},"owners":[{"id":39726,"kind":"person","name":"Huber Reid M","position":1,"cik":"0001607052","reported_name":"Huber Reid M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-15T20:05:09.000Z","date":"2025-09-12","kind":"purchase","planned":false,"acquired":true,"shares":20400,"price":24.4791,"value":499373.64,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $24.23 to $24.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price at which the transactions were effected."}],"balance_after":20400,"source":{"system":"sec-edgar","filing":"0001193125-25-203540","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2012593/000119312525203540/ownership.xml","form_type":"4"}},{"id":1061223,"issuer":{"id":76319,"kind":"organization","name":"CARGO Therapeutics, Inc.","symbol":"CRGX"},"owners":[{"id":39726,"kind":"person","name":"Huber Reid M","position":1,"cik":"0001607052","reported_name":"Huber Reid M","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2025-08-19T20:38:00.000Z","date":"2025-08-19","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Disposed of pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of July 7, 2025, by and among CARGO Therapeutics, Inc. (the \"Issuer\"), Concentra Biosciences, LLC (\"Parent\") and Concentra Merger Sub VII, Inc., a wholly owned subsidiary of Parent (\"Merger Sub\"). On August 18, 2025, Parent and Merger Sub completed a tender offer pursuant to the terms of the Merger Agreement for all outstanding shares of common stock of the Issuer (each, a \"Share\") for an offer price of (i) $4.379 per Share in cash (the \"Cash Amount\"), and (ii) one non-transferable contractual contingent value right (each, a \"CVR\"), subject to and in accordance with the terms of the Contingent Value Rights Agreement (the \"CVR Agreement\"), in each case, without interest, and subject to any applicable withholding taxes (the Cash Amount plus one CVR, collectively, the \"Offer Price\"). [continues to Footnote 2]"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"[continues from Footnote 1] Merger Sub thereafter merged with and into the Issuer, with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of Parent (the \"Merger\"). As of immediately prior to and conditioned upon the effective time of the Merger, pursuant to the Merger Agreement, each outstanding option to purchase Shares (each, an \"Option\") became fully vested and exercisable, and to the extent not exercised prior to the effective time of the Merger, was canceled and converted into the right to receive (a) an amount in cash (without interest and subject to deduction for any required withholding tax) equal to the product of (1) the excess, if any, of the Cash Amount over the exercise price per share of each such Option and (2) the number of Shares underlying such Option immediately prior to the effective time of the Merger [continues to Footnote 3]"},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"[continues from Footnote 2] and (b) one CVR in respect of each Share underlying such Option; provided, however, that if the exercise price per Share of any Option was equal to or greater than the Cash Amount that was then outstanding it was canceled for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Disposed of pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of July 7, 2025, by and among CARGO Therapeutics, Inc. (the \"Issuer\"), Concentra Biosciences, LLC (\"Parent\") and Concentra Merger Sub VII, Inc., a wholly owned subsidiary of Parent (\"Merger Sub\"). On August 18, 2025, Parent and Merger Sub completed a tender offer pursuant to the terms of the Merger Agreement for all outstanding shares of common stock of the Issuer (each, a \"Share\") for an offer price of (i) $4.379 per Share in cash (the \"Cash Amount\"), and (ii) one non-transferable contractual contingent value right (each, a \"CVR\"), subject to and in accordance with the terms of the Contingent Value Rights Agreement (the \"CVR Agreement\"), in each case, without interest, and subject to any applicable withholding taxes (the Cash Amount plus one CVR, collectively, the \"Offer Price\"). [continues to Footnote 2]"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"[continues from Footnote 1] Merger Sub thereafter merged with and into the Issuer, with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of Parent (the \"Merger\"). As of immediately prior to and conditioned upon the effective time of the Merger, pursuant to the Merger Agreement, each outstanding option to purchase Shares (each, an \"Option\") became fully vested and exercisable, and to the extent not exercised prior to the effective time of the Merger, was canceled and converted into the right to receive (a) an amount in cash (without interest and subject to deduction for any required withholding tax) equal to the product of (1) the excess, if any, of the Cash Amount over the exercise price per share of each such Option and (2) the number of Shares underlying such Option immediately prior to the effective time of the Merger [continues to Footnote 3]"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"[continues from Footnote 2] and (b) one CVR in respect of each Share underlying such Option; provided, however, that if the exercise price per Share of any Option was equal to or greater than the Cash Amount that was then outstanding it was canceled for no consideration."}],"balance_after":0,"derivative":{"exercise_price":4.35,"expiration_date":"2035-06-17","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001610717-25-000299","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1607052/000161071725000299/form4.xml","form_type":"4"}},{"id":1104606,"issuer":{"id":76319,"kind":"organization","name":"CARGO Therapeutics, Inc.","symbol":"CRGX"},"owners":[{"id":39726,"kind":"person","name":"Huber Reid M","position":1,"cik":"0001607052","reported_name":"Huber Reid M","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-20T21:43:27.000Z","date":"2025-06-18","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares subject to the option shall vest on the earlier of (i) the one year anniversary of June 18, 2025 or (ii) the next Annual Meeting following June 18, 2025, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":25000,"derivative":{"exercise_price":4.35,"expiration_date":"2035-06-17","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001610717-25-000249","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1607052/000161071725000249/form4.xml","form_type":"4"}},{"id":1106591,"issuer":{"id":4394,"kind":"organization","name":"Rapport Therapeutics, Inc.","symbol":"RAPP"},"owners":[{"id":39726,"kind":"person","name":"Huber Reid M","position":1,"cik":"0001607052","reported_name":"Huber Reid M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-18T20:15:10.000Z","date":"2025-06-17","kind":"grant","planned":false,"acquired":true,"shares":21850,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option shall vest upon the earlier of (i) June 17, 2026 and (ii) the date of the next Annual Meeting of Stockholders of the Issuer, subject to the Reporting Person's continued service on such vesting date."}],"balance_after":21850,"derivative":{"exercise_price":10.95,"expiration_date":"2035-06-17","underlying":"Common Stock","underlying_shares":21850},"source":{"system":"sec-edgar","filing":"0000950170-25-087899","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2012593/000095017025087899/ownership.xml","form_type":"4"}},{"id":1488038,"issuer":{"id":76319,"kind":"organization","name":"CARGO Therapeutics, Inc.","symbol":"CRGX"},"owners":[{"id":39726,"kind":"person","name":"Huber Reid M","position":1,"cik":"0001607052","reported_name":"Huber Reid M","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-06T20:28:51.000Z","date":"2024-06-04","kind":"grant","planned":false,"acquired":true,"shares":23742,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares subject to the option shall vest on the earlier of (i) one year anniversary of June 4, 2024 (the \"Vesting Commencement Date\") or (ii) the next Annual Meeting following June 4, 2024, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":23742,"derivative":{"exercise_price":19.17,"expiration_date":"2034-06-03","underlying":"Common Stock","underlying_shares":23742},"source":{"system":"sec-edgar","filing":"0001610717-24-000299","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1607052/000161071724000299/form4.xml","form_type":"4"}},{"id":1743391,"issuer":{"id":76319,"kind":"organization","name":"CARGO Therapeutics, Inc.","symbol":"CRGX"},"owners":[{"id":39726,"kind":"person","name":"Huber Reid M","position":1,"cik":"0001607052","reported_name":"Huber Reid M","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2023-11-13T23:45:26.000Z","date":"2023-11-09","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/36th of the shares subject to the option vest on each monthly anniversary measured from November 10, 2023 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the third anniversary of the Vesting Commencement Date."}],"balance_after":25000,"derivative":{"exercise_price":15,"expiration_date":"2033-11-08","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001610717-23-000345","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1607052/000161071723000345/form4.xml","form_type":"4"}},{"id":1862574,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":39726,"kind":"person","name":"Huber Reid M","position":1,"cik":"0001607052","reported_name":"Huber Reid M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-09T01:34:20.000Z","date":"2023-06-06","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option shall vest and become exercisable in 12 substantially equal monthly installments over a period of one year beginning on July 6, 2023, subject to the Reporting Person's continuous service  with the Issuer as of each such vesting date."}],"balance_after":30000,"derivative":{"exercise_price":3.55,"expiration_date":"2033-06-06","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0000899243-23-015015","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819133/000089924323015015/doc4.xml","form_type":"4"}},{"id":1862573,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":39726,"kind":"person","name":"Huber Reid M","position":1,"cik":"0001607052","reported_name":"Huber Reid M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-09T01:34:20.000Z","date":"2023-06-06","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares are represented by restricted stock units (the \"RSUs\"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. The RSUs will vest in its entirety on the earlier of: (i) June 6, 2024 and (ii) the date of the next annual meeting of stockholders, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date."}],"balance_after":5000,"source":{"system":"sec-edgar","filing":"0000899243-23-015015","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819133/000089924323015015/doc4.xml","form_type":"4"}},{"id":2049478,"issuer":{"id":107976,"kind":"organization","name":"BELLICUM PHARMACEUTICALS, INC","symbol":"BLCM"},"owners":[{"id":39726,"kind":"person","name":"Huber Reid M","position":1,"cik":"0001607052","reported_name":"Huber Reid M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-20T14:24:51.000Z","date":"2023-01-03","kind":"exercise","acquired":true,"shares":80968,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This amendment is being filed to correct the mathematical error in the amount of securities acquired and the amount of securities beneficially owned following reported transaction on the original Form 4 filed with the SEC on January 5, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This amendment is being filed to correct the mathematical error in the amount of securities acquired and the amount of securities beneficially owned following reported transaction on the original Form 4 filed with the SEC on January 5, 2023."}],"balance_after":146951,"source":{"system":"sec-edgar","filing":"0001628280-23-001321","document":"wf-form4a_167424267625682.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1358403/000162828023001321/wf-form4a_167424267625682.xml","form_type":"4/A","original_submission_date":"2023-01-05"}},{"id":2061935,"issuer":{"id":107976,"kind":"organization","name":"BELLICUM PHARMACEUTICALS, INC","symbol":"BLCM"},"owners":[{"id":39726,"kind":"person","name":"Huber Reid M","position":1,"cik":"0001607052","reported_name":"Huber Reid M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-05T13:12:13.000Z","date":"2023-01-03","kind":"exercise","acquired":true,"shares":87196,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted Restricted Stock Units (\"RSUs\"). Each RSU represents a contingent right to receive one share of BLCM common stock. The RSUs vest in full on January 3, 2024, the one-year anniversary of the grant date."}],"balance_after":153179,"source":{"system":"sec-edgar","filing":"0001628280-23-000420","document":"wf-form4_167294231854390.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1358403/000162828023000420/wf-form4_167294231854390.xml","form_type":"4"}},{"id":2167210,"issuer":{"id":107976,"kind":"organization","name":"BELLICUM PHARMACEUTICALS, INC","symbol":"BLCM"},"owners":[{"id":39726,"kind":"person","name":"Huber Reid M","position":1,"cik":"0001607052","reported_name":"Huber Reid M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-09-02T10:29:44.000Z","date":"2022-09-01","kind":"exercise","acquired":true,"shares":46489,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted Restricted Stock Units (\"RSUs\"). Each RSU represents a contingent right to receive one share of BLCM common stock. The RSUs vest in full on September 1, 2023, the one-year anniversary of the grant date."}],"balance_after":65983,"source":{"system":"sec-edgar","filing":"0001628280-22-024218","document":"wf-form4_166212897072850.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1358403/000162828022024218/wf-form4_166212897072850.xml","form_type":"4"}},{"id":2220314,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":39726,"kind":"person","name":"Huber Reid M","position":1,"cik":"0001607052","reported_name":"Huber Reid M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-28T20:27:06.000Z","date":"2022-06-08","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable in 12 substantially equal monthly installments over a period of one year from June 8, 2022, subject to the Reporting Person's continuous service on the board of directors as of each such vesting date."}],"balance_after":40000,"derivative":{"exercise_price":5.9,"expiration_date":"2032-06-08","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0000899243-22-024396","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819133/000089924322024396/doc4.xml","form_type":"4"}},{"id":2229628,"issuer":{"id":107976,"kind":"organization","name":"BELLICUM PHARMACEUTICALS, INC","symbol":"BLCM"},"owners":[{"id":39726,"kind":"person","name":"Huber Reid M","position":1,"cik":"0001607052","reported_name":"Huber Reid M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-16T14:45:52.000Z","date":"2022-06-15","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest and become exercisable in full on the one-year anniversary of the grant date."}],"balance_after":15000,"derivative":{"exercise_price":1.11,"expiration_date":"2032-06-14","underlying":"Common Stock"},"source":{"system":"sec-edgar","filing":"0001628280-22-017337","document":"wf-form4_165540513956658.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1358403/000162828022017337/wf-form4_165540513956658.xml","form_type":"4"}},{"id":2441128,"issuer":{"id":107976,"kind":"organization","name":"BELLICUM PHARMACEUTICALS, INC","symbol":"BLCM"},"owners":[{"id":39726,"kind":"person","name":"Huber Reid M","position":1,"cik":"0001607052","reported_name":"Huber Reid M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-01-06T09:51:27.000Z","date":"2022-01-04","kind":"exercise","acquired":false,"shares":19494,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest in full upon the one year anniversary of grant date on January 4, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest in full upon the one year anniversary of grant date on January 4, 2021."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":19494},"source":{"system":"sec-edgar","filing":"0001628280-22-000416","document":"wf-form4_164148067397164.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1358403/000162828022000416/wf-form4_164148067397164.xml","form_type":"4"}},{"id":2441127,"issuer":{"id":107976,"kind":"organization","name":"BELLICUM PHARMACEUTICALS, INC","symbol":"BLCM"},"owners":[{"id":39726,"kind":"person","name":"Huber Reid M","position":1,"cik":"0001607052","reported_name":"Huber Reid M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-06T09:51:27.000Z","date":"2022-01-04","kind":"exercise","acquired":true,"shares":19494,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer common stock."}],"balance_after":19494,"source":{"system":"sec-edgar","filing":"0001628280-22-000416","document":"wf-form4_164148067397164.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1358403/000162828022000416/wf-form4_164148067397164.xml","form_type":"4"}},{"id":2639152,"issuer":{"id":107976,"kind":"organization","name":"BELLICUM PHARMACEUTICALS, INC","symbol":"BLCM"},"owners":[{"id":39726,"kind":"person","name":"Huber Reid M","position":1,"cik":"0001607052","reported_name":"Huber Reid M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-07-07T20:27:09.000Z","date":"2021-06-15","kind":"grant","acquired":true,"shares":6500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":6500,"derivative":{"exercise_price":3.05,"exercise_date":"2022-06-15","expiration_date":"2031-06-14","underlying":"Common Stock","underlying_shares":6500},"source":{"system":"sec-edgar","filing":"0001209191-21-045944","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1358403/000120919121045944/doc4.xml","form_type":"4"}},{"id":2919450,"issuer":{"id":107976,"kind":"organization","name":"BELLICUM PHARMACEUTICALS, INC","symbol":"BLCM"},"owners":[{"id":39726,"kind":"person","name":"Huber Reid M","position":1,"cik":"0001607052","reported_name":"Huber Reid M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-01-05T18:37:39.000Z","date":"2021-01-04","kind":"grant","acquired":true,"shares":19494,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (the \"RSU\") represents a contingent right to receive one share of BLCM common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs will vest in full upon the one year anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs will vest in full upon the one year anniversary of the date of grant."}],"balance_after":19494,"derivative":{"underlying":"Common Stock","underlying_shares":19494},"source":{"system":"sec-edgar","filing":"0001628280-21-000097","document":"wf-form4_160988984730933.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1358403/000162828021000097/wf-form4_160988984730933.xml","form_type":"4"}},{"id":3108580,"issuer":{"id":107976,"kind":"organization","name":"BELLICUM PHARMACEUTICALS, INC","symbol":"BLCM"},"owners":[{"id":39726,"kind":"person","name":"Huber Reid M","position":1,"cik":"0001607052","reported_name":"Huber Reid M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-16T16:47:40.000Z","date":"2020-06-15","kind":"grant","acquired":true,"shares":6500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest and become exercisable in full on the one-year anniversary of the grant date."}],"balance_after":6500,"derivative":{"exercise_price":8.42,"expiration_date":"2030-06-14","underlying":"Common Stock","underlying_shares":6500},"source":{"system":"sec-edgar","filing":"0001628280-20-009547","document":"wf-form4_159234044255883.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1358403/000162828020009547/wf-form4_159234044255883.xml","form_type":"4"}},{"id":3489287,"issuer":{"id":107976,"kind":"organization","name":"BELLICUM PHARMACEUTICALS, INC","symbol":"BLCM"},"owners":[{"id":39726,"kind":"person","name":"Huber Reid M","position":1,"cik":"0001607052","reported_name":"Huber Reid M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-06-14T16:04:12.000Z","date":"2019-06-13","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest and become exercisable in full on the one-year anniversary of the grant date."}],"balance_after":25000,"derivative":{"exercise_price":1.96,"expiration_date":"2029-06-12","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001358403-19-000092","document":"wf-form4_156054263689561.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1358403/000135840319000092/wf-form4_156054263689561.xml","form_type":"4"}},{"id":3865691,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":39726,"kind":"person","name":"Huber Reid M","position":1,"cik":"0001607052","reported_name":"Huber Reid M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2018-07-18T20:28:26.000Z","date":"2018-07-16","kind":"tax_withholding","acquired":false,"shares":448,"price":70.19,"value":31445.12,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld automatically by the Issuer to satisfy tax withholding obligations due at settlement of restricted stock units previously reported in Table I as common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 8,026 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":34571,"source":{"system":"sec-edgar","filing":"0001209191-18-043040","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919118043040/doc4.xml","form_type":"4"}},{"id":3873442,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":39726,"kind":"person","name":"Huber Reid M","position":1,"cik":"0001607052","reported_name":"Huber Reid M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Scientific Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2018-07-05T21:04:46.000Z","date":"2018-07-02","kind":"grant","acquired":true,"shares":22772,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Beginning July 2, 2018, options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years."}],"balance_after":22772,"derivative":{"exercise_price":68.62,"expiration_date":"2028-07-01","underlying":"Common Stock","underlying_shares":22772},"source":{"system":"sec-edgar","filing":"0001209191-18-041730","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919118041730/doc4.xml","form_type":"4"}},{"id":3873441,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":39726,"kind":"person","name":"Huber Reid M","position":1,"cik":"0001607052","reported_name":"Huber Reid M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2018-07-05T21:04:46.000Z","date":"2018-07-05","kind":"tax_withholding","acquired":false,"shares":284,"price":68.28,"value":19391.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld automatically by the Issuer to satisfy tax withholding obligations due at settlement of restricted stock units previously reported in Table I as common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 9,415 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":35019,"source":{"system":"sec-edgar","filing":"0001209191-18-041730","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919118041730/doc4.xml","form_type":"4"}},{"id":3890391,"issuer":{"id":107976,"kind":"organization","name":"BELLICUM PHARMACEUTICALS, INC","symbol":"BLCM"},"owners":[{"id":39726,"kind":"person","name":"Huber Reid M","position":1,"cik":"0001607052","reported_name":"Huber Reid M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-06-18T16:31:46.000Z","date":"2018-06-14","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest and become exercisable in equal monthly installments until the Issuer's 2019 Annual Meeting of stockholders."}],"balance_after":10000,"derivative":{"exercise_price":9.8,"expiration_date":"2028-06-13","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001358403-18-000062","document":"wf-form4_152935388699875.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1358403/000135840318000062/wf-form4_152935388699875.xml","form_type":"4"}},{"id":4041858,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":39726,"kind":"person","name":"Huber Reid M","position":1,"cik":"0001607052","reported_name":"Huber Reid M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2018-02-22T21:23:38.000Z","date":"2018-02-21","kind":"sale","acquired":false,"shares":1958,"price":85.55,"value":167506.9,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents weighted average sale price.  Actual sale prices ranged from $85.11 - $86.27."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Reporting person undertakes to provide upon request by Securites and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within range indicated."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Includes an aggregate of 10,294 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":35183,"source":{"system":"sec-edgar","filing":"0001209191-18-012416","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919118012416/doc4.xml","form_type":"4"}},{"id":4041857,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":39726,"kind":"person","name":"Huber Reid M","position":1,"cik":"0001607052","reported_name":"Huber Reid M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2018-02-22T21:23:38.000Z","date":"2018-02-20","kind":"tax_withholding","acquired":false,"shares":1064,"price":86.03,"value":91535.92,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld to satisfy tax withholding obligations due at settlement of restricted stock units previously reported in Table I as common stock."}],"balance_after":37141,"source":{"system":"sec-edgar","filing":"0001209191-18-012416","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919118012416/doc4.xml","form_type":"4"}},{"id":4090307,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":39726,"kind":"person","name":"Huber Reid M","position":1,"cik":"0001607052","reported_name":"Huber Reid M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Scientific Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2018-01-25T21:41:07.000Z","date":"2018-01-24","kind":"grant","acquired":true,"shares":21167,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Beginning January 24, 2018, options become exercisable in full on January 24, 2022."}],"balance_after":21167,"derivative":{"exercise_price":95.34,"expiration_date":"2028-01-23","underlying":"Common Stock","underlying_shares":21167},"source":{"system":"sec-edgar","filing":"0001209191-18-005396","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919118005396/doc4.xml","form_type":"4"}},{"id":4090306,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":39726,"kind":"person","name":"Huber Reid M","position":1,"cik":"0001607052","reported_name":"Huber Reid M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Scientific Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2018-01-25T21:41:07.000Z","date":"2018-01-23","kind":"grant","acquired":true,"shares":12128,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Beginning January 23, 2018, options become exercisable in 37 installments, with the first 25.00% vesting on July 5, 2018 and the remainder vesting monthly over three years."}],"balance_after":12128,"derivative":{"exercise_price":94.63,"expiration_date":"2028-01-22","underlying":"Common Stock","underlying_shares":12128},"source":{"system":"sec-edgar","filing":"0001209191-18-005396","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919118005396/doc4.xml","form_type":"4"}},{"id":4143206,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":39726,"kind":"person","name":"Huber Reid M","position":1,"cik":"0001607052","reported_name":"Huber Reid M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2017-12-05T21:01:25.000Z","date":"2017-12-01","kind":"sale","acquired":false,"shares":696,"price":98.01,"value":68214.96,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 13,316 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":38205,"source":{"system":"sec-edgar","filing":"0001209191-17-063857","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919117063857/doc4.xml","form_type":"4"}},{"id":4208788,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":39726,"kind":"person","name":"Huber Reid M","position":1,"cik":"0001607052","reported_name":"Huber Reid M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2017-09-15T20:24:46.000Z","date":"2017-09-13","kind":"tax_withholding","acquired":false,"shares":692,"price":123.15,"value":85219.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld to satisfy tax withholding obligations due at settlement of restricted stock units previously reported in Table I as common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 13,316 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":38862,"source":{"system":"sec-edgar","filing":"0001209191-17-052975","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919117052975/doc4.xml","form_type":"4"}},{"id":4261255,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":39726,"kind":"person","name":"Huber Reid M","position":1,"cik":"0001607052","reported_name":"Huber Reid M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Scientific Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2017-07-07T20:46:40.000Z","date":"2017-07-05","kind":"grant","acquired":true,"shares":12128,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Beginning July 5, 2017, options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years."}],"balance_after":12128,"derivative":{"exercise_price":128.34,"expiration_date":"2027-07-04","underlying":"Common Stock","underlying_shares":12128},"source":{"system":"sec-edgar","filing":"0001209191-17-044406","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919117044406/doc4.xml","form_type":"4"}},{"id":4261254,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":39726,"kind":"person","name":"Huber Reid M","position":1,"cik":"0001607052","reported_name":"Huber Reid M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2017-07-07T20:46:40.000Z","date":"2017-07-05","kind":"grant","acquired":true,"shares":3517,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents award of restricted stock units (\"RSUs\") that will vest 25% annually over four years, subject to Mr. Huber's continued service with the Issuer through the applicable vesting dates. The RSUs may be settled only for shares of common stock on a one-for-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 11,187 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":39554,"source":{"system":"sec-edgar","filing":"0001209191-17-044406","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919117044406/doc4.xml","form_type":"4"}},{"id":4280451,"issuer":{"id":107976,"kind":"organization","name":"BELLICUM PHARMACEUTICALS, INC","symbol":"BLCM"},"owners":[{"id":39726,"kind":"person","name":"Huber Reid M","position":1,"cik":"0001607052","reported_name":"Huber Reid M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-06-15T16:39:28.000Z","date":"2017-06-14","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest and become exercisable in equal monthly installments until the Issuer's 2018 Annual Meeting of stockholders."}],"balance_after":10000,"derivative":{"exercise_price":10.34,"expiration_date":"2027-06-13","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001358403-17-000095","document":"wf-form4_149755915389119.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1358403/000135840317000095/wf-form4_149755915389119.xml","form_type":"4"}},{"id":4329097,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":39726,"kind":"person","name":"Huber Reid M","position":1,"cik":"0001607052","reported_name":"Huber Reid M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2017-05-09T20:38:07.000Z","date":"2017-05-08","kind":"sale","acquired":false,"shares":8577,"price":119.21,"value":1022464.17,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents weighted average sale price.  Actual sale prices ranged from $117.45 - $121.72."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Reporting person undertakes to provide upon request by Securites and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within range indicated."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Includes an aggregate of 11,187 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":36037,"source":{"system":"sec-edgar","filing":"0001209191-17-030962","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919117030962/doc4.xml","form_type":"4"}},{"id":4329096,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":39726,"kind":"person","name":"Huber Reid M","position":1,"cik":"0001607052","reported_name":"Huber Reid M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2017-05-09T20:38:07.000Z","date":"2017-05-05","kind":"tax_withholding","acquired":false,"shares":7732,"price":125,"value":966500.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld to satisfy tax withholding obligations due at settlement of restricted stock units previously reported in Table I as common stock."}],"balance_after":44614,"source":{"system":"sec-edgar","filing":"0001209191-17-030962","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919117030962/doc4.xml","form_type":"4"}},{"id":4415612,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":39726,"kind":"person","name":"Huber Reid M","position":1,"cik":"0001607052","reported_name":"Huber Reid M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2017-03-01T21:56:12.000Z","date":"2017-02-27","kind":"sale","acquired":false,"shares":2008,"price":131.88,"value":264815.04,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 27,496 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":52262,"source":{"system":"sec-edgar","filing":"0001209191-17-015945","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919117015945/doc4.xml","form_type":"4"}},{"id":4419334,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":39726,"kind":"person","name":"Huber Reid M","position":1,"cik":"0001607052","reported_name":"Huber Reid M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2017-02-28T21:56:56.000Z","date":"2016-02-24","kind":"tax_withholding","acquired":false,"shares":1090,"price":121.95,"value":132925.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares withheld to satisfy tax withholding obligations with respect to vested performance shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 27,496 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":54270,"source":{"system":"sec-edgar","filing":"0001209191-17-015338","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919117015338/doc4.xml","form_type":"4"}},{"id":4419333,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":39726,"kind":"person","name":"Huber Reid M","position":1,"cik":"0001607052","reported_name":"Huber Reid M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2017-02-28T21:56:56.000Z","date":"2016-02-14","kind":"grant","acquired":true,"shares":3098,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares acquired upon vesting of performance shares. Each performance share represented the right to receive one or more shares of common stock based on, and subject to, the achievement of certain clinical and revenue milestones as set forth in the Performance Share Award Agreement.  The number of shares of common stock that the Reporting Person was entitled to receive ranged from 0% to 125% of the number of performance shares awarded. Performance share milestones were achieved at the 100% level."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 27,496 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":55360,"source":{"system":"sec-edgar","filing":"0001209191-17-015338","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919117015338/doc4.xml","form_type":"4"}},{"id":4487174,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":39726,"kind":"person","name":"Huber Reid M","position":1,"cik":"0001607052","reported_name":"Huber Reid M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Scientific Officer"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2017-01-19T21:52:17.000Z","date":"2017-01-17","kind":"grant","acquired":true,"shares":879,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Beginning January 17, 2017, options become exercisable in full on January 17, 2021."}],"balance_after":879,"derivative":{"exercise_price":113.64,"expiration_date":"2027-01-16","underlying":"Common Stock","underlying_shares":879},"source":{"system":"sec-edgar","filing":"0001209191-17-004550","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919117004550/doc4.xml","form_type":"4"}},{"id":4487173,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":39726,"kind":"person","name":"Huber Reid M","position":1,"cik":"0001607052","reported_name":"Huber Reid M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Scientific Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2017-01-19T21:52:17.000Z","date":"2017-01-17","kind":"grant","acquired":true,"shares":17986,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Beginning January 17, 2017, options become exercisable in full on January 17, 2021."}],"balance_after":17986,"derivative":{"exercise_price":113.64,"expiration_date":"2027-01-16","underlying":"Common Stock","underlying_shares":17986},"source":{"system":"sec-edgar","filing":"0001209191-17-004550","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919117004550/doc4.xml","form_type":"4"}},{"id":4487172,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":39726,"kind":"person","name":"Huber Reid M","position":1,"cik":"0001607052","reported_name":"Huber Reid M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Scientific Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2017-01-19T21:52:17.000Z","date":"2017-01-17","kind":"grant","acquired":true,"shares":19091,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Beginning January 17, 2017, options become exercisable in 37 installments, with the first 25.00% vesting on July 15, 2017 and the remainder vesting monthly over three years."}],"balance_after":19091,"derivative":{"exercise_price":113.64,"expiration_date":"2027-01-16","underlying":"Common Stock","underlying_shares":19091},"source":{"system":"sec-edgar","filing":"0001209191-17-004550","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919117004550/doc4.xml","form_type":"4"}},{"id":4493347,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":39726,"kind":"person","name":"Huber Reid M","position":1,"cik":"0001607052","reported_name":"Huber Reid M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2017-01-11T21:21:12.000Z","date":"2017-01-09","kind":"sale","acquired":false,"shares":11739,"price":113.55,"value":1332963.45,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 27,496 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":52185,"source":{"system":"sec-edgar","filing":"0001209191-17-003360","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919117003360/doc4.xml","form_type":"4"}},{"id":4561187,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":39726,"kind":"person","name":"Huber Reid M","position":1,"cik":"0001607052","reported_name":"Huber Reid M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2016-11-10T21:34:58.000Z","date":"2016-11-09","kind":"sale","acquired":false,"shares":2715,"price":109.95,"value":298514.25,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 27,496 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":63924,"source":{"system":"sec-edgar","filing":"0001209191-16-149366","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919116149366/doc4.xml","form_type":"4"}},{"id":4581986,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":39726,"kind":"person","name":"Huber Reid M","position":1,"cik":"0001607052","reported_name":"Huber Reid M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Scientific Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2016-10-11T20:37:46.000Z","date":"2016-10-07","kind":"exercise","acquired":false,"shares":11709,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Beginning February 9, 2013, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years."}],"balance_after":0,"derivative":{"exercise_price":18.32,"expiration_date":"2020-02-08","underlying":"Common Stock","underlying_shares":11709},"source":{"system":"sec-edgar","filing":"0001209191-16-145584","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919116145584/doc4.xml","form_type":"4"}},{"id":4581985,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":39726,"kind":"person","name":"Huber Reid M","position":1,"cik":"0001607052","reported_name":"Huber Reid M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2016-10-11T20:37:46.000Z","date":"2016-10-07","kind":"sale","acquired":false,"shares":11709,"price":96.4,"value":1128747.6,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reporting person undertakes to provide upon request by Securites and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within range indicated."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents weighted average sale price. Actual sale prices ranged from $95.24 - $97.00"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes an aggregate of 27,496 shares of common stock issuable to previously reported restricted stock units that have not vested."}],"balance_after":66601,"source":{"system":"sec-edgar","filing":"0001209191-16-145584","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919116145584/doc4.xml","form_type":"4"}},{"id":4581984,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":39726,"kind":"person","name":"Huber Reid M","position":1,"cik":"0001607052","reported_name":"Huber Reid M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2016-10-11T20:37:46.000Z","date":"2016-10-07","kind":"exercise","acquired":true,"shares":11709,"price":18.32,"value":214508.88,"ownership":{"direct":true},"balance_after":78310,"source":{"system":"sec-edgar","filing":"0001209191-16-145584","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919116145584/doc4.xml","form_type":"4"}}]}